Balance Sheet Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Managed Healthcare

Market Closed - Nasdaq Other stock markets 21:00:00 06/09/2024 BST			5-day change	1st Jan Change
9.500 ^USD	-3.46%		+5.44%	+10.34%

08-16	Alignment Healthcare, Inc. Announces Board and Committee Changes	CI
08-02	UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating	MT

ccc41f1e6d6d4451cf90693f.V46ZzZTkhqTFwdH0opRE2G6YSMNJjJXpJjPDmqGu8RY.Ab7Q-d2X_omOhJK6kOB2qS_uK5F4yOOLbHj6--rPwiED2MiOxJzLxoiTlA

Published financial data: ALIGNMENT HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Premiums and Annuity Revenues	754M	955M	1.17B	1.43B	1.8B
Other Revenues, Total	2.99M	3.83M	688K	2.61M	22.7M
Total Revenues	757M	959M	1.17B	1.43B	1.82B
Policy Benefits	661M	793M	1.04B	1.25B	1.62B
Depreciation & Amortization - (IS) - (Collected)	14.92M	15.1M	15.81M	17.27M	21.41M
Selling General & Admin Expenses, Total	110M	156M	291M	296M	306M
Total Operating Expenses	786M	964M	1.35B	1.56B	1.95B
Operating Income	-29.48M	-5.26M	-178M	-129M	-126M
Interest Expense, Total	-14.9M	-16.93M	-17.44M	-18.29M	-21.23M
Other Non Operating Income (Expenses)	67K	274K	229K	-75K	564K
EBT, Excl. Unusual Items	-44.31M	-21.92M	-195M	-147M	-147M
Gain (Loss) on Sale of Assets	-418K	-1.01M	-	-101K	289K
Legal Settlements	-	-	-	-	-1.9M
Other Unusual Items	-	-	-	-2.2M	-
EBT, Incl. Unusual Items	-44.73M	-22.93M	-195M	-149M	-148M
Income Tax Expense	-	-	-	339K	-22K
Earnings From Continuing Operations	-44.73M	-22.93M	-195M	-150M	-148M
Net Income to Company	-44.73M	-22.93M	-195M	-150M	-148M
Minority Interest	-	-	-	92K	156K
Net Income - (IS)	-44.73M	-22.93M	-195M	-150M	-148M
Net Income to Common Incl Extra Items	-44.73M	-22.93M	-195M	-150M	-148M
Net Income to Common Excl. Extra Items	-44.73M	-22.93M	-195M	-150M	-148M
Per Share Items
Net EPS - Basic	-79	-36.92	-1.14	-0.83	-0.79
Basic EPS - Continuing Operations	-79	-36.92	-1.14	-0.83	-0.79
Basic Weighted Average Shares Outstanding	566K	621K	172M	181M	186M
Net EPS - Diluted	-79	-36.92	-1.14	-0.83	-0.79
Diluted EPS - Continuing Operations	-79	-36.92	-1.14	-0.83	-0.79
Diluted Weighted Average Shares Outstanding	566K	621K	172M	181M	186M
Normalized Basic EPS	-48.92	-22.06	-0.71	-0.51	-0.49
Normalized Diluted EPS	-48.92	-22.06	-0.71	-0.51	-0.49
Supplemental Items
EBITDA	-12.9M	10.2M	-162M	-111M	-104M
EBITA	-29.16M	-4.94M	-178M	-128M	-126M
EBIT	-29.48M	-5.26M	-178M	-129M	-126M
EBITDAR	-	13.87M	-158M	-108M	-102M
Total Revenues (As Reported)	757M	959M	1.17B	1.43B	1.82B
Effective Tax Rate - (Ratio)	-	-	-	-0.23	0.01
Normalized Net Income	-27.7M	-13.7M	-122M	-91.78M	-91.46M
Interest on Long-Term Debt	14.9M	16.93M	17.44M	18.29M	21.23M
Supplemental Operating Expense Items
Advertising Expense	-	-	3.58M	7.96M	6.96M
Selling and Marketing Expenses	-	-	3.58M	7.96M	6.96M
Net Rental Expense, Total	-	3.67M	3.6M	3.37M	2.68M
Imputed Operating Lease Interest Expense	-	3.36M	3.15M	2.99M	2.67M
Imputed Operating Lease Depreciation	-	308K	452K	383K	12.66K
Stock-Based Comp., SG&A Exp. (Total)	1.16M	2.12M	107M	72.59M	59.29M
Stock-Based Comp., Other (Total)	-	-	15.42M	9.13M	7.54M
Total Stock-Based Compensation	1.16M	2.12M	122M	81.72M	66.84M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Total Other Investments	-	-	-	-	116M
Total investments	-	-	-	-	116M
Cash And Equivalents	86.48M	207M	467M	410M	203M
Other Receivables - (Insurance Template)	35.63M	40.14M	58.51M	92.89M	120M
Gross Property Plant And Equipment	85.17M	110M	126M	148M	186M
Accumulated Depreciation	-57.73M	-72.71M	-88.2M	-105M	-124M
Net Property Plant And Equipment	27.44M	37.03M	38.21M	42.99M	61.86M
Goodwill	29.3M	29.3M	29.3M	34.81M	34.83M
Other Intangibles, Total	5.67M	5.34M	5.81M	5.48M	5.25M
Other Current Assets, Total	5.24M	17.22M	27.75M	42.11M	44.97M
Other Long-Term Assets, Total	3.68M	2.15M	4.71M	6.04M	6.4M
Total Assets	193M	339M	631M	634M	592M
Liabilities
Accounts Payable, Total	15.35M	12.32M	13.72M	28.09M	20.88M
Accrued Expenses, Total	115M	138M	150M	198M	240M
Current Portion of Leases	-	3.35M	3.71M	4.2M	1.72M
Long-Term Debt	138M	144M	151M	161M	162M
Long-Term Leases	-	10.27M	6.98M	3.7M	8.97M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	913K
Other Non Current Liabilities	3.94M	-	-	-	-
Total Liabilities	272M	308M	325M	395M	434M
Common Stock, Total	-	-	188K	187K	189K
Additional Paid In Capital	-	-	881M	970M	1.04B
Retained Earnings	-78.71M	30.61M	-575M	-732M	-880M
Total Common Equity	-78.71M	30.61M	306M	238M	157M
Minority Interest	-	-	15K	1.18M	1.12M
Total Equity	-78.71M	30.61M	306M	239M	158M
Total Liabilities And Equity	193M	339M	631M	634M	592M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	566K	621K	187M	187M	189M
ECS Total Common Shares Outstanding	566K	621K	187M	187M	189M
Book Value / Share	-139.02	49.3	1.63	1.27	0.83
Tangible Book Value	-114M	-4.03M	271M	198M	117M
Tangible Book Value Per Share	-200.78	-6.5	1.45	1.06	0.62
Total Debt	138M	158M	161M	169M	173M
Net Debt	51.47M	-49.52M	-305M	-241M	-30.4M
Debt Equivalent Oper. Leases	-	29.36M	28.82M	26.99M	21.46M
Minority Interest, Total (Incl. Fin. Div)	-	-	15K	1.18M	1.12M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	12.25M	12.67M	13.58M	15.44M	15.84M
Full Time Employees	-	775	847	1.04K	1.54K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-44.73M	-22.93M	-195M	-150M	-148M
Depreciation, Depletion & Amortization	16.26M	15.13M	15.67M	17.1M	21.44M
Amortization of Goodwill and Intangible Assets - (CF)	327K	327K	362K	386K	226K
Total Depreciation, Depletion & Amortization	16.58M	15.46M	16.03M	17.49M	21.67M
Amortization of Deferred Charges, Total	1.95M	2.19M	2.25M	1.85M	-
(Gain) Loss On Sale of Asset - (CF)	418K	1.01M	-	611K	-289K
Stock-Based Compensation (CF)	1.16M	2.12M	111M	81.72M	66.84M
Provision and Write-off of Bad Debts	1.42M	118K	111K	150K	91K
Change in Accounts Receivable	-5.78M	-4.63M	-17.61M	-34.38M	-26.95M
Change in Accounts Payable	1.29M	645K	437K	13.74M	-6.35M
Change in Other Net Operating Assets (Collected)	33.48M	7.24M	-2.24M	15.08M	35.32M
Other Operating Activities	3.41M	6.33M	6.93M	7.86M	-1.5M
Cash from Operations	9.21M	7.56M	-78.78M	-45.43M	-59.19M
Capital Expenditure	-10.24M	-15.71M	-19.76M	-23.77M	-36M
Sale of Property, Plant, and Equipment	-	100K	-	-	-
Cash Acquisitions	-	-	-	-4.04M	-
Investment in Marketable and Equity Securities, Total	5K	-750K	-1.05M	-400K	-111M
Cash from Investing	-10.24M	-16.36M	-20.82M	-28.22M	-147M
Long-Term Debt Issued, Total	55M	-	-	165M	-
Total Debt Issued	55M	-	-	165M	-
Long-Term Debt Repaid, Total	-	-	-	-143M	-
Total Debt Repaid	-	-	-	-143M	-
Issuance of Common Stock	500K	135M	391M	-	-
Repurchase of Common Stock	-1.98M	-1.5M	-1.47M	-	-
Other Financing Activities, Total	-854K	-3.37M	-29M	-5.23M	105K
Cash from Financing	52.66M	130M	360M	16.59M	105K
Net Change in Cash	51.63M	121M	261M	-57.05M	-206M
Supplemental Items
Cash Interest Paid	9.53M	10.72M	10.99M	22.45M	19.16M
Net Debt Issued / Repaid	55M	-	-	21.82M	-
Levered Free Cash Flow	-	-6.45M	-17.13M	-1.07M	-150M
Unlevered Free Cash Flow	-	1.94M	-8.48M	8.51M	-136M
Change In Net Working Capital	-	-3.35M	15.46M	-13.48M	110M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-1.24	-22.96	-12.71	-12.84
Return on Total Capital	-	-2.66	-33.94	-18.37	-21.31
Return On Equity %	-	95.33	-116.01	-54.88	-74.58
Return on Common Equity	-	95.33	-116.02	-54.96	-74.93
Margin Analysis
Gross Profit Margin %	12.63	17.33	11.02	12.85	11.02
SG&A Margin	14.55	16.3	24.92	20.61	16.75
EBITDA Margin %	-1.7	1.06	-13.88	-7.75	-5.72
EBITA Margin %	-3.85	-0.51	-15.22	-8.94	-6.89
EBIT Margin %	-3.9	-0.55	-15.25	-8.97	-6.9
Income From Continuing Operations Margin %	-5.91	-2.39	-16.72	-10.43	-8.13
Net Income Margin %	-5.91	-2.39	-16.72	-10.43	-8.12
Net Avail. For Common Margin %	-5.91	-2.39	-16.72	-10.43	-8.12
Normalized Net Income Margin	-3.66	-1.43	-10.45	-6.4	-5.02
Levered Free Cash Flow Margin	-	-0.67	-1.47	-0.07	-8.2
Unlevered Free Cash Flow Margin	-	0.2	-0.73	0.59	-7.47
Asset Turnover
Asset Turnover	-	3.61	2.41	2.27	2.98
Fixed Assets Turnover	-	29.75	31.04	35.32	34.78
Short Term Liquidity
Current Ratio	0.98	1.72	3.31	2.37	1.84
Quick Ratio	0.94	1.61	3.14	2.18	1.67
Operating Cash Flow to Current Liabilities	0.07	0.05	-0.47	-0.2	-0.23
Average Days Payable Outstanding	-	6.39	4.58	6.1	5.51
Long Term Solvency
Total Debt/Equity	-175.27	515.47	52.7	70.54	109.13
Total Debt / Total Capital	232.85	83.75	34.51	41.36	52.18
LT Debt/Equity	-175.27	504.52	51.49	68.78	108.04
Long-Term Debt / Total Capital	232.85	81.97	33.72	40.33	51.66
Total Liabilities / Total Assets	140.69	90.96	51.49	62.25	73.29
EBIT / Interest Expense	-1.98	-0.31	-10.21	-7.03	-5.93
EBITDA / Interest Expense	-0.87	0.82	-9.08	-5.89	-4.78
(EBITDA - Capex) / Interest Expense	-1.55	-0.11	-10.22	-7.19	-6.48
Total Debt / EBITDA	-10.69	11.38	-1.02	-1.57	-1.7
Net Debt / EBITDA	-3.99	-3.57	1.93	2.23	0.3
Total Debt / (EBITDA - Capex)	-5.96	-85.76	-0.91	-1.28	-1.25
Net Debt / (EBITDA - Capex)	-2.22	26.91	1.71	1.83	0.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	26.72	21.74	22.81	27.16
Gross Profit, 1 Yr. Growth %	-	73.93	-22.56	43.15	9.09
EBITDA, 1 Yr. Growth %	-	-179.05	-1.69K	-31.4	-6.21
EBITA, 1 Yr. Growth %	-	-83.07	3.5K	-27.83	-2
EBIT, 1 Yr. Growth %	-	-82.15	3.28K	-27.76	-2.12
Earnings From Cont. Operations, 1 Yr. Growth %	-	-48.75	751.81	-23.37	-0.98
Net Income, 1 Yr. Growth %	-	-48.75	751.81	-23.42	-1.02
Normalized Net Income, 1 Yr. Growth %	-	-50.53	790.9	-24.8	-0.01
Diluted EPS Before Extra, 1 Yr. Growth %	-	-53.27	653.61	-27.33	-3.68
Net Property, Plant and Equip., 1 Yr. Growth %	-	34.95	3.18	12.52	43.88
Total Assets, 1 Yr. Growth %	-	74.99	86.38	0.47	-6.62
Common Equity, 1 Yr. Growth %	-	-138.89	899.77	-22.19	-34.09
Tangible Book Value, 1 Yr. Growth %	-	-96.45	-6.82K	-26.98	-40.93
Cash From Operations, 1 Yr. Growth %	-	-17.89	-1.14K	-42.33	30.29
Capital Expenditures, 1 Yr. Growth %	-	53.32	25.83	20.28	51.4
Levered Free Cash Flow, 1 Yr. Growth %	-	-	165.44	-93.77	5.03K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-538.31	-200.34	-1.7K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	24.21	22.28	24.97
Gross Profit, 2 Yr. CAGR %	-	-	16.06	5.29	24.96
EBITDA, 2 Yr. CAGR %	-	-	254.4	230.14	-19.79
EBITA, 2 Yr. CAGR %	-	-	146.88	409.74	-15.9
EBIT, 2 Yr. CAGR %	-	-	145.76	394.39	-15.91
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	108.94	155.48	-12.89
Net Income, 2 Yr. CAGR %	-	-	108.94	155.4	-12.94
Normalized Net Income, 2 Yr. CAGR %	-	-	109.93	158.84	-13.44
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	85.72	134.01	-16.34
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	18	7.75	27.24
Total Assets, 2 Yr. CAGR %	-	-	80.59	36.84	-3.14
Common Equity, 2 Yr. CAGR %	-	-	97.18	178.91	-28.39
Tangible Book Value, 2 Yr. CAGR %	-	-	54.38	600.3	-34.32
Cash From Operations, 2 Yr. CAGR %	-	-	192.49	145.11	-13.32
Capital Expenditures, 2 Yr. CAGR %	-	-	38.9	23.02	34.95
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-59.32	177.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	109.71	300.79
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	23.74	23.88
Gross Profit, 3 Yr. CAGR %	-	-	-	24.47	6.54
EBITDA, 3 Yr. CAGR %	-	-	-	105.01	117.03
EBITA, 3 Yr. CAGR %	-	-	-	63.85	194.2
EBIT, 3 Yr. CAGR %	-	-	-	63.4	188.15
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	49.56	86.27
Net Income, 3 Yr. CAGR %	-	-	-	49.53	86.21
Normalized Net Income, 3 Yr. CAGR %	-	-	-	49.09	88.29
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	35.84	74.07
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	16.14	18.65
Total Assets, 3 Yr. CAGR %	-	-	-	48.53	20.47
Common Equity, 3 Yr. CAGR %	-	-	-	44.63	72.43
Tangible Book Value, 3 Yr. CAGR %	-	-	-	20.28	207.13
Cash From Operations, 3 Yr. CAGR %	-	-	-	70.24	98.56
Capital Expenditures, 3 Yr. CAGR %	-	-	-	32.39	31.84
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	185.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	312.92